https://orcid.org/0000-0001-6561-575X
Citations (194)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (7)
Efstathia Davoutis, Chrysa Panou, Nikolina Stachika, Christina Dalla & Nikolaos Kokras. (2023) Drug-drug interactions between COVID-19 drug therapies and antidepressants. Expert Opinion on Drug Metabolism & Toxicology 0:0, pages 1-14.
Read now
Read now
Chengyuan Gu, Qian Wu, Jingren Zhang, Liqing Kang, Lei Yu, Huiying Qiu, Depei Wu, Suning Chen & Xiaofei Yang. (2023) Successful treatment of severe cytokine release syndrome after CAR-T therapy by ruxolitinib without compromising CAR-T efficacy. Leukemia & Lymphoma 64:2, pages 495-498.
Read now
Read now
Kanjaksha Ghosh & Kinjalka Ghosh. (2022) Monoclonal antibodies used for the management of hemataological disorders. Expert Review of Hematology 15:5, pages 443-455.
Read now
Read now
Lidia Gatto, Enrico Franceschi, Vincenzo Di Nunno, Ilaria Maggio, Raffaele Lodi & Alba Ariela Brandes. (2021) Engineered CAR-T and novel CAR-based therapies to fight the immune evasion of glioblastoma: gutta cavat lapidem. Expert Review of Anticancer Therapy 21:12, pages 1333-1353.
Read now
Read now
Demis N. Lipe & Sarah Shafer. (2021) CAR-T and checkpoint inhibitors: toxicities and antidotes in the emergency department. Clinical Toxicology 59:5, pages 376-385.
Read now
Read now
Caroline Diorio & David T. Teachey. (2020) Harnessing immunotherapy for pediatric T-cell malignancies. Expert Review of Clinical Immunology 16:4, pages 361-371.
Read now
Read now
Hemant Murthy, Madiha Iqbal, Julio C Chavez & Mohamed A Kharfan-Dabaja. (2019) Cytokine Release Syndrome: Current Perspectives. ImmunoTargets and Therapy 8, pages 43-52.
Read now
Read now
Articles from other publishers (187)
TERRI LYNN SHIGLE & VICTORIA WEHR HANDY. 2024. Manual of Hematopoietic Cell Transplantation and Cellular Therapies. Manual of Hematopoietic Cell Transplantation and Cellular Therapies
145
165
.
Queen L Ekpa, Prince C Akahara, Alexis M Anderson, Omowunmi O Adekoya, Olamide O Ajayi, Peace O Alabi, Okelue E Okobi, Oluwadamilola Jaiyeola & Medara S Ekanem. (2023) A Review of Acute Lymphocytic Leukemia (ALL) in the Pediatric Population: Evaluating Current Trends and Changes in Guidelines in the Past Decade. Cureus.
Crossref
Crossref
Carolina Martinez-King, Sarah H. Chung & Stephen A. McCartney. (2023) Adult-Onset Still’s Disease in Pregnancy: Lessons Learned and an Approach to Subsequent Pregnancies. Reproductive Sciences 30:12, pages 3515-3519.
Crossref
Crossref
Yu Cao, Sergey K. Efetov, Mingze He, Yu Fu, Narasimha M. Beeraka, Jin Zhang, Xinliang Zhang, Namitha Bannimath & Kuo Chen. (2023) Updated Clinical Perspectives and Challenges of Chimeric Antigen Receptor-T Cell Therapy in Colorectal Cancer and Invasive Breast Cancer. Archivum Immunologiae et Therapiae Experimentalis 71:1.
Crossref
Crossref
Geoffrey D. E. Cuvelier, Kristjan Paulson & Eric J. Bow. (2023) Updates in hematopoietic cell transplant and cellular therapies that enhance the risk for opportunistic infections. Transplant Infectious Disease 25:S1.
Crossref
Crossref
Chieh Yang, John Nguyen & Yun Yen. (2023) Complete spectrum of adverse events associated with chimeric antigen receptor (CAR)-T cell therapies. Journal of Biomedical Science 30:1.
Crossref
Crossref
Matteo Amicucci, Valentina Simioli, Valentina De Cecco, Laura Orlando, Italo Ciaralli, Alessandra Buccino, Barbara Guidi, Giovanna Locatelli, Claudia Palmieri, Martina Piazzalunga, Romina Proietti, Agnese Pucci & Stefano Botti. (2023) Nursing Management in Pediatric Patients Undergoing Chimeric Antigen Receptor T (CAR-T) Cell Therapy: A Systematic Literature Review. Seminars in Oncology Nursing 39:5, pages 151478.
Crossref
Crossref
Ivana Milošević, Aleksandra Barać, Jaroslava Jovanović, Ankica Vujović, Goran Stevanović, Nevena Todorović & Branko Milošević. (2023) A single-center experience of early administration of tocilizumab and corticosteroids in patients with COVID-19 pneumonia. Transactions of The Royal Society of Tropical Medicine and Hygiene 117:9, pages 668-672.
Crossref
Crossref
Concetta Rafaniello, Valerio Liguori, Alessia Zinzi, Mario Gaio, Angela Falco, Luigi Di Costanzo, Francesca Gargano, Valentina Trimarco, Mauro Cataldi & Annalisa Capuano. (2023) A Pharmacovigilance Study on the Safety of Axicabtagene Ciloleucel Based on Spontaneous Reports from the EudraVigilance Database. Biomedicines 11:8, pages 2162.
Crossref
Crossref
Linghui Zhou, Weijun Fu, Shenghao Wu, Kailin Xu, Lugui Qiu, Yang Xu, Xiaojing Yan, Qing Zhang, Mingming Zhang, Linqin Wang, Ruimin Hong, Alex H. Chang, Jian Yu, Shan Fu, Delin Kong, Lu Li, Ying Wang, Zhenyu Li, Huawei Jiang, Jing Huang, Zhi Liu, Na Su, Guoqing Wei, Yongxian Hu & He Huang. (2023)
Derivation and validation of a novel score for early prediction of severe
CRS
after
CAR‐T
therapy in haematological malignancy patients: A multi‐centre study
. British Journal of Haematology 202:3, pages 517-524.
Crossref
Crossref
Mina Rezghi Rami, Maryam Meskini, Nahid Rezaei Khozani, Shayan Forouzandehdel, Saeideh Momtaz, Soumya Ghosh, Nima Rezaei & Amir Hossein Abdolghaffari. (2023) Therapeutic Potentials and Candidates for COVID-19. Iranian Journal of Science 47:4, pages 1283-1297.
Crossref
Crossref
Tingting Zhang, Weiwei Tian, Shuang Wei, Xinyi Lu, Jing An, Shaolong He, Jie Zhao, Zhilin Gao, Li Li, Ke Lian, Qiang Zhou, Huilai Zhang, Liang Wang, Liping Su, Huicong Kang, Ting Niu, Ailin Zhao, Jing Pan, Qingqing Cai, Zhenshu Xu, Wenming Chen, Hongmei Jing, Peng Li, Wanhong Zhao, Yang Cao, Jianqing Mi, Tao Chen, Yuan Chen, Ping Zou, Veronika Lukacs-Kornek, Christian Kurts, Jian Li, Xiansheng Liu, Qi Mei, Yicheng Zhang & Jia Wei. (2023) Multidisciplinary recommendations for the management of CAR-T recipients in the post-COVID-19 pandemic era. Experimental Hematology & Oncology 12:1.
Crossref
Crossref
Namthip Kaewbandit, Ashwini Malla, Wanuttha Boonyayothin, Kaewta Rattanapisit, Thareeya Phetphoung, Nuttapat Pisuttinusart, Richard Strasser, Rattana Saetung, Supannikar Tawinwung & Waranyoo Phoolcharoen. (2023) Effect of plant produced Anti-hIL-6 receptor antibody blockade on pSTAT3 expression in human peripheral blood mononuclear cells. Scientific Reports 13:1.
Crossref
Crossref
Aparimita Das, Aruni Ghose, Kevin Naicker, Elisabet Sanchez, Cyrus Chargari, Elie Rassy & Stergios Boussios. (2023) Advances in adoptive T-cell therapy for metastatic melanoma. Current Research in Translational Medicine 71:3, pages 103404.
Crossref
Crossref
Peizhen Geng, Yuhua Chi, Yuan Yuan, Maoquan Yang, Xiaohua Zhao, Zhengchun Liu, Guangwei Liu, Yihui Liu, Liang Zhu & Shuai Wang. (2023) Novel chimeric antigen receptor T cell-based immunotherapy: a perspective for triple-negative breast cancer. Frontiers in Cell and Developmental Biology 11.
Crossref
Crossref
Renu Dharra, Anil Kumar Sharma & Sonal Datta. (2023) Emerging aspects of cytokine storm in COVID-19: the role of proinflammatory cytokines and therapeutic prospects. Cytokine, pages 156287.
Crossref
Crossref
Dayna McManus, Matthew W. Davis, Alex Ortiz, Clemente Britto-Leon, Charles S. Dela Cruz & Jeffrey E. Topal. (2023) Immunomodulatory Agents for Coronavirus Disease-2019 Pneumonia. Clinics in Chest Medicine 44:2, pages 299-319.
Crossref
Crossref
Xin Jin, Tingting Qiu, Li Li, Rilei Yu, Xiguang Chen, Changgui Li, Christopher G. Proud & Tao Jiang. (2023) Pathophysiology of obesity and its associated diseases. Acta Pharmaceutica Sinica B 13:6, pages 2403-2424.
Crossref
Crossref
Nunzio Cennamo, Angelantonio Piccirillo, Debora Bencivenga, Francesco Arcadio, Marco Annunziata, Fulvio Della Ragione, Luigi Guida, Luigi Zeni & Adriana Borriello. (2023) Towards a point-of-care test to cover atto-femto and pico-nano molar concentration ranges in interleukin 6 detection exploiting PMMA-based plasmonic biosensor chips. Talanta 256, pages 124284.
Crossref
Crossref
Tsung-Hsien Chen, Chia-Jung Chang & Peir-Haur Hung. (2023) Possible Pathogenesis and Prevention of Long COVID: SARS-CoV-2-Induced Mitochondrial Disorder. International Journal of Molecular Sciences 24:9, pages 8034.
Crossref
Crossref
Aleksandra Zielińska, Piotr Eder, Jacek Karczewski, Marlena Szalata, Szymon Hryhorowicz, Karolina Wielgus, Milena Szalata, Agnieszka Dobrowolska, Atanas G. Atanasov, Ryszard Słomski & Eliana B. Souto. (2023) Tocilizumab-coated solid lipid nanoparticles loaded with cannabidiol as a novel drug delivery strategy for treating COVID-19: A review. Frontiers in Immunology 14.
Crossref
Crossref
Jerry C. Lee & Aaron C. Logan. (2023) Diagnosis and Management of Adult Malignancy-Associated Hemophagocytic Lymphohistiocytosis. Cancers 15:6, pages 1839.
Crossref
Crossref
Chinmay T. Jani, Robert T. Schooley, Rana R. Mckay & Scott M. Lippman. (2023) Cancer, more than a “COVID-19 co-morbidity”. Frontiers in Oncology 13.
Crossref
Crossref
Han-Qi Wang, Ruxing Fu, Qi-Wen Man, Guang Yang, Bing Liu & Lin-Lin Bu. (2023) Advances in CAR-T Cell Therapy in Head and Neck Squamous Cell Carcinoma. Journal of Clinical Medicine 12:6, pages 2173.
Crossref
Crossref
Martin Abild Stengaard Meyer, Mette Bjerre, Sebastian Wiberg, Johannes Grand, Laust Emil Roelsgaard Obling, Anna Sina Pettersson Meyer, Jakob Josiassen, Martin Frydland, Jakob Hartvig Thomsen, Ruth Frikke-Schmidt, Jesper Kjaergaard & Christian Hassager. (2023) Modulation of inflammation by treatment with tocilizumab after out-of-hospital cardiac arrest and associations with clinical status, myocardial- and brain injury. Resuscitation 184, pages 109676.
Crossref
Crossref
Alireza Zafarani, Mohammad Hossein Razizadeh, Salar Pashangzadeh, Mohammad Reza Amirzargar, Mahsa Taghavi-Farahabadi & Mohammad Mahmoudi. (2023) Natural killer cells in COVID-19: from infection, to vaccination and therapy. Future Virology 18:3, pages 177-191.
Crossref
Crossref
Erika Yue Lee & Baruch D. Jakubovic. (2023) Interleukin-6 and cytokine release syndrome. Annals of Allergy, Asthma & Immunology 130:2, pages 178-184.
Crossref
Crossref
Makoto Takada, Ichika Watanabe, Kazuya Naito, Junpei Mutoh, Yoshihito Ohba, Tsutomu Kabashima & Mitsuhiro Wada. (2023) Extremely Simple and Rapid HPLC Analysis of Tocilizumab in Human Serum with Selective Precipitation Using Alkylamine. Chemical and Pharmaceutical Bulletin 71:1, pages 19-23.
Crossref
Crossref
Ruaa Kareem Surhan & Mayyada F. Darweesh. (2023) Efficacy of Pfizer vaccine on IL-12/IFN-γ pathway with related to COVID-19 infection. BIO Web of Conferences 65, pages 05003.
Crossref
Crossref
John M. Bridges & Walter Winn Chatham. 2023. Clinical Immunology. Clinical Immunology
1089
1101
.
Elliott T. Worku, Katrina Ki & Kiran Shekar. 2023. Cardiopulmonary Bypass. Cardiopulmonary Bypass
1003
1020
.
Gopi S. Mohan, Daniel J. Kats, Samantha D. Martin & Pietro Miozzo. 2023. Palliative Care in Hematologic Malignancies and Serious Blood Disorders. Palliative Care in Hematologic Malignancies and Serious Blood Disorders
55
67
.
Thomas R. Spitzer. 2023. Pulmonary and Critical Care Considerations of Hematopoietic Stem Cell Transplantation. Pulmonary and Critical Care Considerations of Hematopoietic Stem Cell Transplantation
211
219
.
Abdolreza Esmaeilzadeh, Davood Jafari, Reza Elahi, Mahsa Bazargan, Maryam Zare Rafie & Amir Hossein Mansourabadi. 2023.
Djamila MERGHACHE. (2022) The main treatments used for SARS-CoV-2 patients. Algerian Journal of Biosciences 3:2, pages 095-103.
Crossref
Crossref
Qian Gao, Xuedong Yin, Boyu Tan, Junshi Wang, Jiayan Chen, Bin Zhao, Qiaoling Yang & Zhiling Li. (2022) Drug-induced liver injury following the use of tocilizumab or sarilumab in patients with coronavirus disease 2019. BMC Infectious Diseases 22:1.
Crossref
Crossref
Kimia Ghasemi & Kosar Ghasemi. (2022) Evaluation of the Tocilizumab therapy in human cancers: Latest evidence and clinical potential. Journal of Clinical Pharmacy and Therapeutics 47:12, pages 2360-2368.
Crossref
Crossref
Haitham M.H. Qutob, Ramadan A. Saad, Hamza Bali, Abdulaziz Osailan, Jumana Jaber, Emad Alzahrani, Jamilah Alyami, Hani Elsayed, Raed Alserihi & Osama A. Shaikhomar. (2022) Impact of dexamethasone and tocilizumab on hematological parameters in COVID-19 patients with chronic disease. Medicina Clínica 159:12, pages 569-574.
Crossref
Crossref
Haitham M.H. Qutob, Ramadan A. Saad, Hamza Bali, Abdulaziz Osailan, Jumana Jaber, Emad Alzahrani, Jamilah Alyami, Hani Elsayed, Raed Alserihi & Osama A. Shaikhomar. (2022) Impact of dexamethasone and tocilizumab on hematological parameters in COVID-19 patients with chronic disease. Medicina Clínica (English Edition) 159:12, pages 569-574.
Crossref
Crossref
Karol Sadowski, Wioletta Olejarz & Grzegorz Basak. (2022) Modern Advances in CARs Therapy and Creating a New Approach to Future Treatment. International Journal of Molecular Sciences 23:23, pages 15006.
Crossref
Crossref
N. V. Lomakin, B. A. Bakirov, G. H. Musaev, V. V. Popov, E. A. Smolyarchuk, Yu. N. Linkova, D. V. Bogdan, A. V. Eremeeva, P. S. Pukhtinskaia, M. A. Morozova, A. V. Zinkina-Orikhan & A. A. Lutckii. (2022) Levilimab clinical efficacy for interleukin-6 receptor inhibition in COVID-19 and its potential for treating cytokine release syndrome of other aetiologies. Biological Products. Prevention, Diagnosis, Treatment 22:4, pages 446-459.
Crossref
Crossref
Xinyi Wang, Guozheng Tang, Yuchen Liu, Lizhi Zhang, Bangjie Chen, Yanxun Han, Ziyue Fu, Liuning Wang, Guangzhi Hu, Qing Ma, Shuyan Sheng, Jianpeng Wang, Xinyang Hu & Song Shao. (2022) The role of IL-6 in coronavirus, especially in COVID-19. Frontiers in Pharmacology 13.
Crossref
Crossref
Li-Rong Chen, Ya-Jia Li, Zheng Zhang, Ping Wang, Tao Zhou, Kai Qian, Yu-Xin Fan, Yu Guo, Gong-Hao He & Lei Shen. (2022) Cardiovascular effects associated with chimeric antigen receptor T cell therapy in cancer patients: A meta-analysis. Frontiers in Oncology 12.
Crossref
Crossref
Milo Gatti & Federico Pea. (2022) The Cytokine Release Syndrome and/or the Proinflammatory Cytokines as Underlying Mechanisms of Downregulation of Drug Metabolism and Drug Transport: A Systematic Review of the Clinical Pharmacokinetics of Victim Drugs of this Drug–Disease Interaction Under Different Clinical Conditions. Clinical Pharmacokinetics 61:11, pages 1519-1544.
Crossref
Crossref
Tianning Gu, Kejia Hu, Xiaohui Si, Yongxian Hu & He Huang. (2022)
Mechanisms of immune effector
cell‐associated
neurotoxicity syndrome after
CAR‐T
treatment
. WIREs Mechanisms of Disease 14:6.
Crossref
Crossref
Ismael F. Aomar-Millán, Juan Salvatierra & Enrique Raya Álvarez. (2022) Efecto del tocilizumab frente a cuidado estándar en pacientes adultos hospitalizados con neumonía por COVID-19 moderada-grave. Medicina Clínica 159:8, pages e54.
Crossref
Crossref
Ismael F. Aomar-Millán, Juan Salvatierra & Enrique Raya Álvarez. (2022) Effect of tocilizumab versus standard of care in adults hospitalized with moderate-severe COVID-19 pneumonia. Medicina Clínica (English Edition) 159:8, pages e54.
Crossref
Crossref
Zhuoyu Zhang, Lunan Liu, Chao Ma & Weiqiang Chen. (2022) A Computational Model of Cytokine Release Syndrome during CAR T‐Cell Therapy. Advanced Therapeutics 5:10.
Crossref
Crossref
Srinivas Balagopal, Koichi Sasaki, Pooja Kaur, Maria Nikolaidi & Jun Ishihara. (2022) Emerging approaches for preventing cytokine release syndrome in CAR-T cell therapy. Journal of Materials Chemistry B 10:37, pages 7491-7511.
Crossref
Crossref
Ju Yeon Kim, Miso Kim, Jin Kyun Park, Eun Bong Lee, Jun Won Park & Junshik Hong. (2022) Limited efficacy of tocilizumab in adult patients with secondary hemophagocytic lymphohistiocytosis: a retrospective cohort study. Orphanet Journal of Rare Diseases 17:1.
Crossref
Crossref
Rikke Boedker Holmstroem, Ole Haagen Nielsen, Søren Jacobsen, Lene Buhl Riis, Susann Theile, Jacob Tveiten Bjerrum, Peter Vilmann, Julia Sidenius Johansen, Mogens Karsbøl Boisen, Rikke Helene Løvendahl Eefsen, Inge Marie Svane, Dorte Lisbet Nielsen & Inna Markovna Chen. (2022) COLAR: open-label clinical study of IL-6 blockade with tocilizumab for the treatment of immune checkpoint inhibitor-induced colitis and arthritis. Journal for ImmunoTherapy of Cancer 10:9, pages e005111.
Crossref
Crossref
Johannes Kast, Saeideh Nozohouri, Di Zhou, Marc R. Yago, Po‐Wei Chen, Malidi Ahamadi, Sandeep Dutta & Vijay V. Upreti. (2022) Recent advances and clinical pharmacology aspects of Chimeric Antigen Receptor (CAR) T‐cellular therapy development. Clinical and Translational Science 15:9, pages 2057-2074.
Crossref
Crossref
Wen-Jie Gong, Yan Qiu, Ming-Hao Li, Li-Yun Chen, Yan-Yan Li, Jing-Qiu Yu, Li-Qing Kang, Ai-Ning Sun, De-Pei Wu, Lei Yu & Sheng-Li Xue. (2022) Investigation of the risk factors to predict cytokine release syndrome in relapsed or refractory B-cell acute lymphoblastic leukemia patients receiving IL-6 knocking down anti-CD19 chimeric antigen receptor T-cell therapy. Frontiers in Immunology 13.
Crossref
Crossref
Maciej Borówka, Stanisław Łącki-Zynzeling, Michał Nicze, Sylwia Kozak & Jerzy Chudek. (2022) Adverse Renal Effects of Anticancer Immunotherapy: A Review. Cancers 14:17, pages 4086.
Crossref
Crossref
Lynette Miroslava Pacheco-HernándezJazmín Ariadna Ramírez-NoyolaItzel Alejandra Gómez-GarcíaSergio Ignacio-CortésJoaquín ZúñigaJosé Alberto Choreño-Parra. (2022) Comparing the Cytokine Storms of COVID-19 and Pandemic Influenza. Journal of Interferon & Cytokine Research 42:8, pages 369-392.
Crossref
Crossref
Mallory R. Taylor, Cecilia J. Hillard, William R. Drobyski, Aniko Szabo, Bryon D. Johnson, Fenlu Zhu, Charles L. Raison, Steve W. Cole & Jennifer M. Knight. (2022) The effect of tocilizumab on patient reported outcomes and inflammatory biomarkers in hematopoietic cell transplantation. Brain, Behavior, & Immunity - Health 23, pages 100480.
Crossref
Crossref
Anna Lebedeva, Ivan Molodtsov, Alexandra Anisimova, Anastasia Berestovskaya, Oleg Dukhin, Antonina Elizarova, Wendy Fitzgerald, Darya Fomina, Kseniya Glebova, Oxana Ivanova, Anna Kalinskaya, Anastasia Lebedeva, Maryana Lysenko, Elena Maryukhnich, Elena Misyurina, Denis Protsenko, Alexander Rosin, Olga Sapozhnikova, Denis Sokorev, Alexander Shpektor, Daria Vorobyeva, Elena Vasilieva & Leonid Margolis. (2022) Comprehensive Cytokine Profiling of Patients with COVID-19 Receiving Tocilizumab Therapy. International Journal of Molecular Sciences 23:14, pages 7937.
Crossref
Crossref
Puri Ferreros & Isabel Trapero. (2022) Interleukin Inhibitors in Cytokine Release Syndrome and Neurotoxicity Secondary to CAR-T Therapy. Diseases 10:3, pages 41.
Crossref
Crossref
Jennifer M. Knight, Mallory R. Taylor, Kelly E. Rentscher, Elisabeth C. Henley, Hannah A. Uttley, Ashley M. Nelson, Lucie M. Turcotte, Natalie S. McAndrew, Hermioni L. Amonoo, Lathika Mohanraj, Debra Lynch Kelly & Erin S. Costanzo. (2022) Biobehavioral Implications of Covid-19 for Transplantation and Cellular Therapy Recipients. Frontiers in Immunology 13.
Crossref
Crossref
Mahsa Mohammadi, Maryam Akhoundi, Sara Malih, Ali Mohammadi & Mohsen Sheykhhasan. (2022) Therapeutic roles of CAR T cells in infectious diseases: Clinical lessons learnt from cancer. Reviews in Medical Virology 32:4.
Crossref
Crossref
Elaine Tan Su Yin, Yong Xian Hu & He Huang. (2022) The breakthrough and the future: CD20 chimeric antigen receptor T‐cell therapy for hematologic malignancies. ImmunoMedicine 2:1.
Crossref
Crossref
Patrycja Śliwa-Tytko, Agnieszka Kaczmarska, Monika Lejman & Joanna Zawitkowska. (2022) Neurotoxicity Associated with Treatment of Acute Lymphoblastic Leukemia Chemotherapy and Immunotherapy. International Journal of Molecular Sciences 23:10, pages 5515.
Crossref
Crossref
B Čemusová. (2022) Cytokine release syndrome after CAR T-cell therapy: a review of the literature and our experience. Anesteziologie a intenzivní medicína 33:2, pages 90-96.
Crossref
Crossref
M. Elsayed Mohamed, Khalid Farouk, G. Alansary Mohamed, Abdelaziz Ahmed, A. Shawky Mohamed, S. Taha Sameh, Hosny Amr & M. Elhallag Motaz. (2022) Does Tocilizumab Influence the Outcome of Patients with COVID-19 Pneumonia Compared to the Standard Therapy? Retrospective Analysis of Data Obtained during Phase I COVID Pandemic. Open Access Macedonian Journal of Medical Sciences 10:B, pages 1383-1391.
Crossref
Crossref
O. A. Gavrilina, G. M. Galstyan, A. E. Shchekina, E. S. Kotova, M. A. Maschan, V. V. Troitskaya, D. A. Koroleva, E. E. Zvonkov, Z. T. Fidarova, V. A. Vasilyeva & E. N. Parovichnikova. (2022) Chimeric antigen receptor T-cell therapy in adult patients with B-cell lymphoproliferative diseases. Russian journal of hematology and transfusiology 67:1, pages 8-28.
Crossref
Crossref
Mohadeseh Mirzaee Godarzee, Bashdar Mahmud Hussen, Ehsan Razmara, Benyamin Hakak‐Zargar, Fatemeh Mohajerani, Hamed Dabiri, Mohammed Fatih Rasul, Mohammad Hossein Ghazimoradi, Sadegh Babashah & Majid Sadeghizadeh. (2022) Strategies to overcome the side effects of chimeric antigen receptor T cell therapy. Annals of the New York Academy of Sciences 1510:1, pages 18-35.
Crossref
Crossref
Lidia Gatto, Vincenzo Di Nunno, Enrico Franceschi, Alicia Tosoni, Stefania Bartolini & Alba Ariela Brandes. (2022) Pharmacotherapeutic Treatment of Glioblastoma: Where Are We to Date?. Drugs 82:5, pages 491-510.
Crossref
Crossref
Courtney M. Rowan, Lincoln Smith, Matthew P. Sharron, Laura LoftisSapna KudchadkarChristine N. DuncanFrancis PikePaul A. CarpenterDavid JacobsohnCatherine M. BollardConrad Russell Y. CruzAbhijeet Malatpure, Sherif FaragJamie RenbargerMorgan R. LittlePhillip R. GafkenRobert A. KranceKenneth R. CookeSophie Paczesny. (2022) A biomarker panel for risk of early respiratory failure following hematopoietic cell transplantation. Blood Advances 6:6, pages 1866-1878.
Crossref
Crossref
Sabrina Orzetti, Federica Tommasi, Antonella Bertola, Giorgia Bortolin, Elisabetta Caccin, Sara Cecco, Emanuela Ferrarin, Elisa Giacomin & Paolo Baldo. (2022) Genetic Therapy and Molecular Targeted Therapy in Oncology: Safety, Pharmacovigilance, and Perspectives for Research and Clinical Practice. International Journal of Molecular Sciences 23:6, pages 3012.
Crossref
Crossref
Muhammet Gülhan, Uğur Önal, Neşe Demirci, Gulcan Cetin, Abdullah Calisir, Damla Köksalan, Kübra Solmaz, Ayhan Kars, Cetin Kilinc & Sedat Gülten. (2022) Tocilizumab is useful for coronavirus disease 2019 patients: the key point is timing. Revista da Associação Médica Brasileira 68:3, pages 318-322.
Crossref
Crossref
Alessandro Cozzi-Lepri, Colette Smith & Cristina Mussini. (2022) Signals were broadly positive for months, but never definitive: the tocilizumab story. Clinical Microbiology and Infection 28:3, pages 371-374.
Crossref
Crossref
Arbind Kumar, Aashish Sharma, Narendra Vijay Tirpude, Suresh Sharma, Yogendra S. Padwad & Sanjay Kumar. (2022) Pharmaco-immunomodulatory interventions for averting cytokine storm-linked disease severity in SARS-CoV-2 infection. Inflammopharmacology 30:1, pages 23-49.
Crossref
Crossref
Wenyujing Zhou, Weihong Chen, Xiaochun Wan, Changru Luo, Xin Du, Xiaoqing Li, Qian Chen, Ruiwen Gao, Xiaohan Zhang, Mei Xie & Mingjun Wang. (2022) Benefits of Chimeric Antigen Receptor T-Cell Therapy for B-Cell Lymphoma. Frontiers in Genetics 12.
Crossref
Crossref
Sourya Acharya, Sunil Kumar, Dhruv Talwar, Nitin Raisinghani, Sparsh Madaan, Vidyashree Hulkoti, Annadatha Akhilesh, Shivam Khanna, Divit Shah & Shubham Nimkar. (2022) Interleukin 6 and Its Correlation with COVID-19 in Terms of Outcomes in an Intensive Care Unit of a Rural Hospital: A Cross-sectional Study. Indian Journal of Critical Care Medicine 26:1, pages 39-42.
Crossref
Crossref
Minghao Li, Sheng-Li Xue, Xiaowen Tang, Jiayu Xu, Suning Chen, Yue Han, Huiying Qiu, Miao Miao, Nan Xu, Jingwen Tan, Liqing Kang, Zhou Yu, Xiaoyan Lou, Yang Xu, Jia Chen, Zhiqiang Yan, Weixing Feng, Depei Wu & Lei Yu. (2022) The differential effects of tumor burdens on predicting the net benefits of ssCART-19 cell treatment on r/r B-ALL patients. Scientific Reports 12:1.
Crossref
Crossref
Pratik Raval, BennyJose Panakkal, Dinesh Joshi, Karthik Natrajan, Anand Shukla, Gajendra Dubey, Sibasis Sahoo & Subhendu Bajpai. (2022) A retrospective analysis of moderate and severe COVID-19 pneumonia with special reference to the use of Adjuvant Tocilizumab. Archives of Medicine and Health Sciences 10:2, pages 176.
Crossref
Crossref
Shira Buchrits, Danielle Fredman, Kim Ben Tikva Kagan & Anat Gafter-Gvili. (2022) A Systematic Review Assessing the Underrepresentation of Cancer Patients in COVID-19 Trials. Acta Haematologica 145:3, pages 235-243.
Crossref
Crossref
Patricia M. de Groot, Octavio Arevalo, Komal Shah, Chad D. Strange, Girish S. Shroff, Jitesh Ahuja, Mylene T. Truong, John F. de GrootIoannis Vlahos. (2022) Imaging Primer on Chimeric Antigen Receptor T-Cell Therapy for Radiologists. RadioGraphics 42:1, pages 176-194.
Crossref
Crossref
Laura E. Hogan, Luke D. Maese, Keith J. August & Jennifer L. McNeer. 2022. Clinical Management of Acute Lymphoblastic Leukemia. Clinical Management of Acute Lymphoblastic Leukemia
75
104
.
Rodrigo L. Castillo, Alejandro Gonzaléz-Candia & Alejandro A. Candia. (2021) Pathophysiology of Acute Respiratory Failure by CoV-2 Infection: Role of Oxidative Stress, Endothelial Dysfunction and Obesity. The Open Respiratory Medicine Journal 15:1, pages 76-81.
Crossref
Crossref
Kyeong-Min Kim, So-Yeon Kim, Tamanna Jahan Mony, Ho Jung Bae, Sang-Deok Han, Eun-Seok Lee, Seung-Hyuk Choi, Sun Hee Hong, Sang-Deok Lee & Se Jin Park. (2021) Dracocephalum moldavica Ethanol Extract Suppresses LPS-Induced Inflammatory Responses through Inhibition of the JNK/ERK/NF-κB Signaling Pathway and IL-6 Production in RAW 264.7 Macrophages and in Endotoxic-Treated Mice. Nutrients 13:12, pages 4501.
Crossref
Crossref
Zixun Yin, Ya Zhang & Xin Wang. (2021) Advances in chimeric antigen receptor T-cell therapy for B-cell non-Hodgkin lymphoma. Biomarker Research 9:1.
Crossref
Crossref
Demis N. Lipe, Eva Rajha, Adriana H. Wechsler, Susan Gaeta, Nicolas L. Palaskas, Zahra Alhajji, Jayne Viets-Upchurch & Patrick Chaftari. (2021) Cardiotoxicity associated with immune checkpoint inhibitors and CAR T-cell therapy. The American Journal of Emergency Medicine 50, pages 51-58.
Crossref
Crossref
Infante Barbara, Mercuri Silvia, Troise Dario, Castellano Giuseppe & Giovanni Stallone. (2021) Case Report: Tocilizumab for Acute Kidney Graft Dysfunction in Patient Affected by COVID-19. Frontiers in Medicine 8.
Crossref
Crossref
Chiranjib Chakraborty, Ashish Ranjan Sharma, Manojit Bhattacharya, Govindasamy Agoramoorthy & Sang-Soo Lee. (2021) The Drug Repurposing for COVID-19 Clinical Trials Provide Very Effective Therapeutic Combinations: Lessons Learned From Major Clinical Studies. Frontiers in Pharmacology 12.
Crossref
Crossref
Tor Henrik Anderson Tvedt, Anh Khoi Vo, Øystein Bruserud & Håkon Reikvam. (2021) Cytokine Release Syndrome in the Immunotherapy of Hematological Malignancies: The Biology behind and Possible Clinical Consequences. Journal of Clinical Medicine 10:21, pages 5190.
Crossref
Crossref
Christos Kyriakopoulos, Georgios Ntritsos, Athena Gogali, Haralampos Milionis, Evangelos Evangelou & Konstantinos Kostikas. (2021)
Tocilizumab administration for the treatment of hospitalized patients with
COVID
‐19: A systematic review and meta‐analysis
. Respirology 26:11, pages 1027-1040.
Crossref
Crossref
Anja Meyer, Shuaifeng Yan, Viktoria Golumba-Nagy, Ruth L. Esser, Verena Barbarino, Stuart J. Blakemore, Lisa Rusyn, Anastasia Nikiforov, Tamina Seeger-Nukpezah, Holger Grüll, Christian P. Pallasch & David M. Kofler. (2021) Kinase activity profiling reveals contribution of G-protein signaling modulator 2 deficiency to impaired regulatory T cell migration in rheumatoid arthritis. Journal of Autoimmunity 124, pages 102726.
Crossref
Crossref
Katie L. Collins, Usir S. Younis, Sasipa Tanyaratsrisakul, Robin Polt, Meredith Hay, Heidi M. Mansour & Julie G. Ledford. (2021) Angiotensin-(1–7) Peptide Hormone Reduces Inflammation and Pathogen Burden during Mycoplasma pneumoniae Infection in Mice. Pharmaceutics 13:10, pages 1614.
Crossref
Crossref
Luca MONTINI, Gennaro DE PASCALE, Giuseppe BELLO, Domenico L. GRIECO, Giacomo GRASSELLI, Antonio PESENTI, Vito M. RANIERI, Maurizio CECCONI, Enzo D’ARCANGELO, Elisa GREMESE & Massimo ANTONELLI. (2021) Compassionate use of anti-IL6 receptor antibodies in critically ill patients with acute respiratory distress syndrome due to SARS-CoV-2. Minerva Anestesiologica 87:10.
Crossref
Crossref
Chen WuDawei LinFei MaFeng JiangYaosheng Wang. (2021) New progress in elucidating the relationship between cancer therapy and cardiovascular toxicity. BioScience Trends 15:4, pages 211-218.
Crossref
Crossref
Sanjay Chandrasekaran, Christopher Ronald Funk, Troy Kleber, Chrystal M. Paulos, Mala Shanmugam & Edmund K. Waller. (2021) Strategies to Overcome Failures in T-Cell Immunotherapies by Targeting PI3K-δ and –γ. Frontiers in Immunology 12.
Crossref
Crossref
Adriana Fodor, Brandusa Tiperciuc, Cezar Login, Olga H. Orasan, Andrada L. Lazar, Cristina Buchman, Patricia Hanghicel, Adela Sitar-Taut, Ramona Suharoschi, Romana Vulturar & Angela Cozma. (2021) Endothelial Dysfunction, Inflammation, and Oxidative Stress in COVID-19—Mechanisms and Therapeutic Targets. Oxidative Medicine and Cellular Longevity 2021, pages 1-15.
Crossref
Crossref
Lianhan Shang, David Chien Lye & Bin Cao. (2021)
Contemporary narrative review of treatment options for
COVID
‐19
. Respirology 26:8, pages 745-767.
Crossref
Crossref
Rajendra Karki & Thirumala-Devi Kanneganti. (2021) The ‘cytokine storm’: molecular mechanisms and therapeutic prospects. Trends in Immunology 42:8, pages 681-705.
Crossref
Crossref
Bahareh Hafezi, Lily Chan, Jason P. Knapp, Negar Karimi, Kimia Alizadeh, Yeganeh Mehrani, Byram W. Bridle & Khalil Karimi. (2021) Cytokine Storm Syndrome in SARS-CoV-2 Infections: A Functional Role of Mast Cells. Cells 10:7, pages 1761.
Crossref
Crossref
Mihaela Aldea, Jean-Marie Michot, Francois-Xavier Danlos, Antoni Ribas & Jean-Charles Soria. (2021) Repurposing of Anticancer Drugs Expands Possibilities for Antiviral and Anti-Inflammatory Discovery in COVID-19. Cancer Discovery 11:6, pages 1336-1344.
Crossref
Crossref
Runxia Gu, Tianyang Mao, Qiao Lu, Tina Tianjiao Su & Jun Wang. (2021) Myeloid dysregulation and therapeutic intervention in COVID-19. Seminars in Immunology 55, pages 101524.
Crossref
Crossref
Alessio Mazzoni, Lorenzo Salvati, Laura Maggi, Francesco Annunziato & Lorenzo Cosmi. (2021) Hallmarks of immune response in COVID-19: Exploring dysregulation and exhaustion. Seminars in Immunology 55, pages 101508.
Crossref
Crossref
Kanjaksha GhoshKinjalka Ghosh. (2021) Monoclonal antibodies used for management of hematological disorders. Journal of Hematology and Allied Sciences 1, pages 12-21.
Crossref
Crossref
Hong-Jin Chen, Ting Meng, Ping-Jin Gao & Cheng-Chao Ruan. (2021) The Role of Brown Adipose Tissue Dysfunction in the Development of Cardiovascular Disease. Frontiers in Endocrinology 12.
Crossref
Crossref
Senol Kobak. (2021) The Perfect Storm: A Rheumatologist's Point of View on COVID-19 Infection. Current Rheumatology Reviews 17:2, pages 141-152.
Crossref
Crossref
Virginia S. Hahn, Kathleen W. ZhangLova Sun, Vivek Narayan, Daniel J. Lenihan & Bonnie Ky. (2021) Heart Failure With Targeted Cancer Therapies. Circulation Research 128:10, pages 1576-1593.
Crossref
Crossref
Shanmugaraj Kulanthaivel, Vitalii B. Kaliberdenko, Keerthanaa Balasundaram, Michael V. Shterenshis, Emidio Scarpellini & Ludovico Abenavoli. (2021) Tocilizumab in SARS-CoV-2 Patients with the Syndrome of Cytokine Storm: A Narrative Review. Reviews on Recent Clinical Trials 16:2, pages 138-145.
Crossref
Crossref
Aldo Venuti, Sara Donzelli, Paola Nisticò, Giovanni Blandino & Gennaro Ciliberto. (2021) Does Interleukin-6 Bridge SARS-CoV-2 With Virus-Associated Cancers?. Journal of Immunotherapy and Precision Oncology 4:2, pages 79-85.
Crossref
Crossref
Jan Mieszkowski, Andżelika Borkowska, Błażej Stankiewicz, Andrzej Kochanowicz, Bartłomiej Niespodziński, Marcin Surmiak, Tomasz Waldziński, Rafał Rola, Miroslav Petr & Jędrzej Antosiewicz. (2021) Single High-Dose Vitamin D Supplementation as an Approach for Reducing Ultramarathon-Induced Inflammation: A Double-Blind Randomized Controlled Trial. Nutrients 13:4, pages 1280.
Crossref
Crossref
Francisco López-Medrano, María Asunción Pérez-Jacoiste Asín, Mario Fernández-Ruiz, Octavio Carretero, Antonio Lalueza, Guillermo Maestro de la Calle, José Manuel Caro, Cristina de la Calle, Mercedes Catalán, Rocío García-García, Joaquín Martínez-López, Julia Origüen, Mar Ripoll, Rafael San Juan, Hernando Trujillo, Ángel Sevillano, Eduardo Gutiérrez, Borja de Miguel, Fernando Aguilar, Carlos Gómez, José Tiago Silva, Daniel García-Ruiz de Morales, Miguel Saro-Buendía, Ángel Marrero-Sánchez, Guillermo Chiara-Graciani, Héctor Bueno, Estela Paz-Artal, Carlos Lumbreras, José L. Pablos & José María Aguado. (2021) Combination therapy with tocilizumab and corticosteroids for aged patients with severe COVID-19 pneumonia: A single-center retrospective study. International Journal of Infectious Diseases 105, pages 487-494.
Crossref
Crossref
Ajeet Singh, Sudhir Bhandari & Govind Rankawat. (2021) Tocilizumab: An Effective Therapy for Severely and Critically Ill COVID-19 Patients. Indian Journal of Critical Care Medicine 25:3, pages 260-266.
Crossref
Crossref
Lina Ghosn, Anna Chaimani, Theodoros Evrenoglou, Mauricia Davidson, Carolina Graña, Christine Schmucker, Claudia Bollig, Nicholas Henschke, Yanina Sguassero, Camilla Hansen Nejstgaard, Sonia Menon, Thu Van Nguyen, Gabriel Ferrand, Philipp Kapp, Carolina Riveros, Camila Ávila, Declan Devane, Joerg J Meerpohl, Gabriel Rada, Asbjørn Hróbjartsson, Giacomo Grasselli, David Tovey, Philippe Ravaud & Isabelle Boutron. (2021) Interleukin-6 blocking agents for treating COVID-19: a living systematic review. Cochrane Database of Systematic Reviews 2021:3.
Crossref
Crossref
Eleanor Quek, Hasan Tahir, Poornima Kumar, Robert Hastings & Rajeev Jha. (2021) Treatment of COVID-19: a review of current and prospective pharmacotherapies. British Journal of Hospital Medicine 82:3, pages 1-9.
Crossref
Crossref
Zheng Xian Thng, Marc D De Smet, Cecilia S Lee, Vishali Gupta, Justine R Smith, Peter J McCluskey, Jennifer E Thorne, John H Kempen, Manfred Zierhut, Quan Dong Nguyen, Carlos Pavesio & Rupesh Agrawal. (2021) COVID-19 and immunosuppression: a review of current clinical experiences and implications for ophthalmology patients taking immunosuppressive drugs. British Journal of Ophthalmology 105:3, pages 306-310.
Crossref
Crossref
Emma H. Baker, Kamal Patel, Jonathan Ball, Sarah Edwards, Thomas S. Harrison, Arvind Kaul, Mickey Koh, Sanjeev Krishna, Susannah Leaver, Vinodh Kumar & Daniel M. Forton. (2020) Insights from compassionate use of tocilizumab for COVID‐19 to inform appropriate design of randomised controlled trials. British Journal of Clinical Pharmacology 87:3, pages 1584-1586.
Crossref
Crossref
Ashley F. Stein-Merlob, Michael V. Rothberg, Patrick Holman & Eric H. Yang. (2021) Immunotherapy-Associated Cardiotoxicity of Immune Checkpoint Inhibitors and Chimeric Antigen Receptor T Cell Therapy: Diagnostic and Management Challenges and Strategies. Current Cardiology Reports 23:3.
Crossref
Crossref
A. V. Ershov, V. D. Surova, V. T. Dolgikh & T. I. Dolgikh. (2021) Cytokine Storm in the Novel Coronavirus Infection and Methods of its Correction. Antibiotics and Chemotherapy 65:11-12, pages 27-37.
Crossref
Crossref
Rozita Khodashahi, Hamidreza Naderi, Amin Bojdy & Mandana Khodashahi. (2021) Effectiveness of Antiviral and Immunomodulatory Agents in the Treatment of COVID-19: A Systematic Review. Current Respiratory Medicine Reviews 16:3, pages 165-183.
Crossref
Crossref
Andrea Claudio Comel, Walter Mosaner, Damiano Bragantini & Massimiliano Lanzafame. (2020) Rapid radiological improvement of COVID-19 pneumonia after treatment with tocilizumab. Infection 49:1, pages 195-196.
Crossref
Crossref
Mario Fernández‐Ruiz, Francisco López‐Medrano, María Asunción Pérez‐Jacoiste Asín, Guillermo Maestro de la Calle, Héctor Bueno, José Manuel Caro‐Teller, Mercedes Catalán, Cristina de la Calle, Rocío García‐García, Carlos Gómez, Rocío Laguna‐Goya, Manuel Lizasoáin, Joaquín Martínez‐López, Julia Origüen, José Luis Pablos, Mar Ripoll, Rafael San Juan, Hernando Trujillo, Carlos Lumbreras & José María Aguado. (2020) Tocilizumab for the treatment of adult patients with severe COVID‐19 pneumonia: A single‐center cohort study. Journal of Medical Virology 93:2, pages 831-842.
Crossref
Crossref
Nicholas Fordham, Emma Baker, Daniel Forton, Matthias Klammer, Kamal Patel, Dara Qadir, Yasmin Reyal, Fenella Willis & Mickey B.C. Koh. (2020) First reported case of safe and efficacious use of tocilizumab for treatment of hyperinflammatory syndrome associated with COVID‐19 in an allogeneic stem cell transplant patient. eJHaem 2:1, pages 143-146.
Crossref
Crossref
Yujing Song, Yuxuan Ye, Shiuan-Haur Su, Andrew Stephens, Tao Cai, Meng-Ting Chung, Meilan K. Han, Michael W. Newstead, Lenar Yessayan, David Frame, H. David Humes, Benjamin H. Singer & Katsuo Kurabayashi. (2021) A digital protein microarray for COVID-19 cytokine storm monitoring. Lab on a Chip 21:2, pages 331-343.
Crossref
Crossref
Kristin E Burke, Bharati Kochar, Jessica R Allegretti, Rachel W Winter, Paul Lochhead, Hamed Khalili, Francis P Colizzo, Matthew J Hamilton, Walter W Chan & Ashwin N Ananthakrishnan. (2021) Immunosuppressive Therapy and Risk of COVID-19 Infection in Patients With Inflammatory Bowel Diseases. Inflammatory Bowel Diseases 27:2, pages 155-161.
Crossref
Crossref
Alexandra Pum, Maria Ennemoser, Tiziana Adage & Andreas J. Kungl. (2021) Cytokines and Chemokines in SARS-CoV-2 Infections—Therapeutic Strategies Targeting Cytokine Storm. Biomolecules 11:1, pages 91.
Crossref
Crossref
Srinivasan Sanjay, Ankush Kawali, Padmamalini Mahendradas & Rohit Shetty. (2021) Lockdown effects on a patient receiving immunosuppression for unilateral HLA- B27 associated uveitis during COVID-19 pandemic. Indian Journal of Ophthalmology 69:5, pages 1351.
Crossref
Crossref
Laura Castelnovo, Antonio Tamburello, Alfredo Lurati, Eleonora Zaccara, Maria Grazia Marrazza, Micol Olivetti, Nicola Mumoli, Daniela Mastroiacovo, Daniele Colombo, Elisabetta Ricchiuti, Paolo Vigano’, Faggioli Paola & Antonino Mazzone. (2021) Anti-IL6 treatment of serious COVID-19 disease. Medicine 100:1, pages e23582.
Crossref
Crossref
Bo Zhang, Yan Wang, Shenlong Huang, Jiaqi Sun, Min Wang, Wenxiao Ma, Yanbo You, Ling Wu, Jin Hu, Wei Song, Xudong Liu, Shengjie Li, Hua Chen, Guisheng Zhang, Lihe Zhang, Demin Zhou, Lingjun Li & Xuan Zhang. (2021) Photoswitchable CAR-T Cell Function In Vitro and In Vivo via a Cleavable Mediator. Cell Chemical Biology 28:1, pages 60-69.e7.
Crossref
Crossref
Erica Bacca, Margherita Digaetano, Marianna Meschiari, Erica Franceschini, Marianna Menozzi, Gianluca Cuomo & Cristina Mussini. (2021) Immunomodulation for the management of severe SARS-CoV2 infections. State of the art and review of the literature. Biochemical and Biophysical Research Communications 538, pages 151-155.
Crossref
Crossref
J. A. George & E. S. Mayne. 2021. Clinical, Biological and Molecular Aspects of COVID-19. Clinical, Biological and Molecular Aspects of COVID-19
127
138
.
Thomas R. Spitzer. (2020) Cytokine syndromes associated with hematopoietic cellular therapy. ADVANCES IN CELL AND GENE THERAPY 4:1.
Crossref
Crossref
David McBride, Matthew Kerr, Nicholas Dorn, Dora Ogbonna, Evan Santos & Nisarg Shah. (2020) Triggers, Timescales, and Treatments for Cytokine-Mediated Tissue Damage. EMJ Innovations.
Crossref
Crossref
Xiaoling XuMingfeng Han, Tiantian LiWei SunDongsheng Wang, Binqing Fu, Yonggang ZhouXiaohu ZhengYun Yang, Xiuyong Li, Xiaohua ZhangAijun PanHaiming Wei. (2020) Reply to Wang et al.: Tocilizumab treatment should be used in a timely manner, at suitable dose, and in suitable patients. Proceedings of the National Academy of Sciences 117:49, pages 30898-30899.
Crossref
Crossref
Jing Zhang, Yiqun Hao, Wuling Ou, Fei Ming, Gai Liang, Yu Qian, Qian Cai, Shuang Dong, Sheng Hu, Weida Wang & Shaozhong Wei. (2020) Serum interleukin-6 is an indicator for severity in 901 patients with SARS-CoV-2 infection: a cohort study. Journal of Translational Medicine 18:1.
Crossref
Crossref
Bassam Atallah, Wasim El Nekidy, Saad I. Mallah, Antoine Cherfan, Laila AbdelWareth, Jihad Mallat & Fadi Hamed. (2020) Thrombotic events following tocilizumab therapy in critically ill COVID-19 patients: a Façade for prognostic markers. Thrombosis Journal 18:1.
Crossref
Crossref
Alberto Mella, Silvia Mingozzi, Ester Gallo, Antonio Lavacca, Maura Rossetti, Roberta Clari, Olga Randone, Stefano Maffei, Mario Salomone, Daniele Imperiale & Luigi Biancone. (2020) Case series of six kidney transplanted patients with COVID‐19 pneumonia treated with tocilizumab. Transplant Infectious Disease 22:6.
Crossref
Crossref
Tristan E. Knight. (2020) Severe Acute Respiratory Syndrome Coronavirus 2 and Coronavirus Disease 2019: A Clinical Overview and Primer. Biopreservation and Biobanking 18:6, pages 492-502.
Crossref
Crossref
Lorenzo Salvati, Mariaelena Occhipinti, Leonardo Gori, Luca Ciani, Alessio Mazzoni, Laura Maggi, Manuela Capone, Paola Parronchi, Francesco Liotta, Vittorio Miele, Francesco Annunziato, Federico Lavorini & Lorenzo Cosmi. (2020) Pulmonary vascular improvement in severe COVID-19 patients treated with tocilizumab. Immunology Letters 228, pages 122-128.
Crossref
Crossref
Jamie A.G. Hamilton & Curtis J. Henry. (2020) Aging and immunotherapies: New horizons for the golden ages. Aging and Cancer 1:1-4, pages 30-44.
Crossref
Crossref
Sudeendra Gupta, Rakesh Madhyastha, Fadi Hamed, Maher Balkis, Wasim El Nekidy & Nizar Attallah. (2020) Tocilizumab Use in a Chronic Hemodialysis Patient for the Management of COVID-19-Associated Pneumonia and Acute Respiratory Distress Syndrome. Case Reports in Nephrology 2020, pages 1-5.
Crossref
Crossref
Tyler C. LewisSamrachana AdhikariVasishta TatapudiMeredith HolubDennis KunichoffAndrea B. TroxelRobert A. MontgomeryDaniel H. Sterman. (2020) A Propensity-Matched Cohort Study of Tocilizumab in Patients With Coronavirus Disease 2019. Critical Care Explorations 2:11, pages e0283.
Crossref
Crossref
Abdur Rauf, Tareq Abu-Izneid, Ahmed Olatunde, Anees Ahmed Khalil, Fahad A. Alhumaydhi, Tabussam Tufail, Mohammad Ali Shariati, Maksim Rebezov, Zainab M. Almarhoon, Yahia N. Mabkhot, Abdulrhman Alsayari & Kannan R. R. Rengasamy. (2020) COVID-19 Pandemic: Epidemiology, Etiology, Conventional and Non-Conventional Therapies. International Journal of Environmental Research and Public Health 17:21, pages 8155.
Crossref
Crossref
Hernando Trujillo, Fernando Caravaca‐Fontán, Ángel Sevillano, Eduardo Gutiérrez, Mario Fernández‐Ruiz, Francisco López‐Medrano, Ana Hernández, José María Aguado, Manuel Praga & Amado Andrés. (2020) Tocilizumab use in Kidney Transplant Patients with COVID‐19. Clinical Transplantation 34:11.
Crossref
Crossref
Jumanah Algazaq, Cristian Hiraldo-Infante & John Miskovsky. (2020) Tocilizumab Treatment in COVID-19–induced Cytokine Release Syndrome. Infectious Diseases in Clinical Practice 28:6, pages e76-e78.
Crossref
Crossref
E. Nasonov & M. Samsonov. (2020) The role of Interleukin 6 inhibitors in therapy of severe COVID-19. Biomedicine & Pharmacotherapy 131, pages 110698.
Crossref
Crossref
Caroline Streicher, Xavier Engalenc, Marion Gaudin, Guillaume Vignaud, Annick Daulange & Bruno Abraham. (2020) Could Tocilizumab be an Attractive Therapeutic Option for Elderly Patients with Severe COVID-19? A Case Report. Clinical Drug Investigation 40:11, pages 1085-1088.
Crossref
Crossref
Saba Shamim, Maryam Khan, Zelal Jaber Kharaba, Munazza Ijaz & Ghulam Murtaza. (2020) Potential strategies for combating COVID-19. Archives of Virology 165:11, pages 2419-2438.
Crossref
Crossref
E. L. Nasonov. (2020) Coronavirus disease-2019 (COVID-19): value of IL-6 inhibitors. PULMONOLOGIYA 30:5, pages 629-644.
Crossref
Crossref
Stephen P. Hunger & Elizabeth A. Raetz. (2020) How I treat relapsed acute lymphoblastic leukemia in the pediatric population. Blood 136:16, pages 1803-1812.
Crossref
Crossref
Weilei Hu, Guosheng Wang, Yian Wang, Matthew J. Riese & Ming You. (2020) Uncoupling Therapeutic Efficacy from Immune-Related Adverse Events in Immune Checkpoint Blockade. iScience 23:10, pages 101580.
Crossref
Crossref
Mihe Hong, Justin D. Clubb & Yvonne Y. Chen. (2020) Engineering CAR-T Cells for Next-Generation Cancer Therapy. Cancer Cell 38:4, pages 473-488.
Crossref
Crossref
Kenneth E Remy, Scott C Brakenridge, Bruno Francois, Thomas Daix, Clifford S Deutschman, Guillaume Monneret, Robin Jeannet, Pierre-Francois Laterre, Richard S Hotchkiss & Lyle L Moldawer. (2020) Immunotherapies for COVID-19: lessons learned from sepsis. The Lancet Respiratory Medicine 8:10, pages 946-949.
Crossref
Crossref
Sylwia Jasinski, Francis Andrew De Los Reyes, Gloria Contreras Yametti, Joanna Pierro, Elizabeth Raetz & William L. Carroll. (2020) Immunotherapy in Pediatric B-Cell Acute Lymphoblastic Leukemia: Advances and Ongoing Challenges. Pediatric Drugs 22:5, pages 485-499.
Crossref
Crossref
Adnane Guella, Osman Elfadil, Ghisson Abdulrazaq, Sahla Osman, Mohammed Munir Khan, Abdalla Ahmed & Feras Deyab. (2020) Favorable Outcome of COVID-19 Pneumonia in a Kidney Transplant Recipient Treated with Tocilizumab. Case Reports in Infectious Diseases 2020, pages 1-4.
Crossref
Crossref
Parménides Guadarrama-Ortiz, José Alberto Choreño-Parra, Claudia Marisol Sánchez-Martínez, Francisco Javier Pacheco-Sánchez, Alberto Iván Rodríguez-Nava & Gabriela García-Quintero. (2020) Neurological Aspects of SARS-CoV-2 Infection: Mechanisms and Manifestations. Frontiers in Neurology 11.
Crossref
Crossref
Pinar Ataca Atilla, Mary K McKenna, Haruko Tashiro, Madhuwanti Srinivasan, Feiyan Mo, Norihiro Watanabe, Brian Wesley Simons, Alexandra McLean Stevens, Michele S Redell, Helen E Heslop, Maksim Mamonkin, Malcolm K Brenner & Erden Atilla. (2020) Modulating TNFα activity allows transgenic IL15-Expressing CLL-1 CAR T cells to safely eliminate acute myeloid leukemia. Journal for ImmunoTherapy of Cancer 8:2, pages e001229.
Crossref
Crossref
Fabian Freitag, Marius Maucher, Zeno Riester & Michael Hudecek. (2020) New targets and technologies for CAR-T cells. Current Opinion in Oncology 32:5, pages 510-517.
Crossref
Crossref
Shifaa M. Abdin, Sara M. Elgendy, Shatha K. Alyammahi, Dima W. Alhamad & Hany A. Omar. (2020) Tackling the cytokine storm in COVID-19, challenges and hopes. Life Sciences 257, pages 118054.
Crossref
Crossref
Calvin A. Omolo, Nikki Soni, Victoria Oluwaseun Fasiku, Irene Mackraj & Thirumala Govender. (2020) Update on therapeutic approaches and emerging therapies for SARS-CoV-2 virus. European Journal of Pharmacology 883, pages 173348.
Crossref
Crossref
Sajad Khiali, Elnaz Khani & Taher Entezari‐Maleki. (2020) A Comprehensive Review of Tocilizumab in COVID‐19 Acute Respiratory Distress Syndrome. The Journal of Clinical Pharmacology 60:9, pages 1131-1146.
Crossref
Crossref
Chuang Guo, Bin Li, Huan Ma, Xiaofang Wang, Pengfei Cai, Qiaoni Yu, Lin Zhu, Liying Jin, Chen Jiang, Jingwen Fang, Qian Liu, Dandan Zong, Wen Zhang, Yichen Lu, Kun Li, Xuyuan Gao, Binqing Fu, Lianxin Liu, Xiaoling Ma, Jianping Weng, Haiming Wei, Tengchuan Jin, Jun Lin & Kun Qu. (2020) Single-cell analysis of two severe COVID-19 patients reveals a monocyte-associated and tocilizumab-responding cytokine storm. Nature Communications 11:1.
Crossref
Crossref
Vincenzo Montesarchio, Roberto Parella, Chiara Iommelli, Antonella Bianco, Elio Manzillo, Fiorentino Fraganza, Cristiana Palumbo, Gaetano Rea, Patrizia Murino, Rosanna De Rosa, Luigi Atripaldi, Maurizio D’Abbraccio, Marcello Curvietto, Domenico Mallardo, Egidio Celentano, Antonio Maria Grimaldi, Marco Palla, Claudia Trojaniello, Maria Grazia Vitale, Samuel Lewis Million-Weaver & Paolo Antonio Ascierto. (2020) Outcomes and biomarker analyses among patients with COVID-19 treated with interleukin 6 (IL-6) receptor antagonist sarilumab at a single institution in Italy. Journal for ImmunoTherapy of Cancer 8:2, pages e001089.
Crossref
Crossref
Efstathios Kastritis, Ashutosh Wechalekar, Stefan Schönland, Vaishali Sanchorawala, Giampaolo Merlini, Giovanni Palladini, Monique Minnema, Murielle Roussel, Arnaud Jaccard, Ute Hegenbart, Shaji Kumar, Maria T. Cibeira, Joan Blade & Meletios A. Dimopoulos. (2020) Challenges in the management of patients with systemic light chain (AL) amyloidosis during the COVID‐19 pandemic. British Journal of Haematology 190:3, pages 346-357.
Crossref
Crossref
Florian Slimano, Amandine Baudouin, Jérémie Zerbit, Anne Toulemonde-Deldicque, Audrey Thomas-Schoemann, Régine Chevrier, Mikaël Daouphars, Isabelle Madelaine, Bertrand Pourroy, Jean-François Tournamille, Alain Astier, Florence Ranchon, Jean-Louis Cazin, Christophe Bardin & Catherine Rioufol. (2020) Cancer, immune suppression and Coronavirus Disease-19 (COVID-19): Need to manage drug safety (French Society for Oncology Pharmacy [SFPO] guidelines). Cancer Treatment Reviews 88, pages 102063.
Crossref
Crossref
Giovanni Guaraldi, Marianna Meschiari, Alessandro Cozzi-Lepri, Jovana Milic, Roberto Tonelli, Marianna Menozzi, Erica Franceschini, Gianluca Cuomo, Gabriella Orlando, Vanni Borghi, Antonella Santoro, Margherita Di Gaetano, Cinzia Puzzolante, Federica Carli, Andrea Bedini, Luca Corradi, Riccardo Fantini, Ivana Castaniere, Luca Tabbì, Massimo Girardis, Sara Tedeschi, Maddalena Giannella, Michele Bartoletti, Renato Pascale, Giovanni Dolci, Lucio Brugioni, Antonello Pietrangelo, Andrea Cossarizza, Federico Pea, Enrico Clini, Carlo Salvarani, Marco Massari, Pier Luigi Viale & Cristina Mussini. (2020) Tocilizumab in patients with severe COVID-19: a retrospective cohort study. The Lancet Rheumatology 2:8, pages e474-e484.
Crossref
Crossref
Eddie W. Fakhouri, Stephen J. Peterson, Janish Kothari, Ragin Alex, Joseph I. Shapiro & Nader G. Abraham. (2020) Genetic Polymorphisms Complicate COVID-19 Therapy: Pivotal Role of HO-1 in Cytokine Storm. Antioxidants 9:7, pages 636.
Crossref
Crossref
Faryal Farooqi, Naveen Dhawan, Richard Morgan, John Dinh, Kester Nedd & George Yatzkan. (2020) Treatment of Severe COVID-19 with Tocilizumab Mitigates Cytokine Storm and Averts Mechanical Ventilation during Acute Respiratory Distress: A Case Report and Literature Review. Tropical Medicine and Infectious Disease 5:3, pages 112.
Crossref
Crossref
Nina Shah, Jack Aiello, David E Avigan, Jesus G Berdeja, Ivan M Borrello, Ajai Chari, Adam D Cohen, Karthik Ganapathi, Lissa Gray, Damian Green, Amrita Krishnan, Yi Lin, Elisabet Manasanch, Nikhil C Munshi, Ajay K Nooka, Aaron P Rapoport, Eric L Smith, Ravi Vij & Madhav Dhodapkar. (2020) The Society for Immunotherapy of Cancer consensus statement on immunotherapy for the treatment of multiple myeloma. Journal for ImmunoTherapy of Cancer 8:2, pages e000734.
Crossref
Crossref
Michelle Lubetzky, Meredith J Aull, Rebecca Craig-Schapiro, John R Lee, Jehona Marku-Podvorica, Thalia Salinas, Laura Gingras, Jun B Lee, Samuel Sultan, Rosy Priya Kodiyanplakkal, Choli Hartono, Stuart Saal, Thangamani Muthukumar, Sandip Kapur, Manikkam Suthanthiran & Darshana M Dadhania. (2020) Kidney allograft recipients, immunosuppression, and coronavirus disease-2019: a report of consecutive cases from a New York City transplant center. Nephrology Dialysis Transplantation 35:7, pages 1250-1261.
Crossref
Crossref
Sara Galimberti, Chiara Baldini, Claudia Baratè, Federica Ricci, Serena Balducci, Susanna Grassi, Francesco Ferro, Gabriele Buda, Edoardo Benedetti, Rita Fazzi, Laura Baglietto, Ersilia Lucenteforte, Antonello Di Paolo & Mario Petrini. (2020) The CoV-2 outbreak: how hematologists could help to fight Covid-19. Pharmacological Research 157, pages 104866.
Crossref
Crossref
Yang Cao, Jia Wei, Liang Zou, Tiebin Jiang, Gaoxiang Wang, Liting Chen, Liang Huang, Fankai Meng, Lifang Huang, Na Wang, Xiaoxi Zhou, Hui Luo, Zekai Mao, Xing Chen, Jungang Xie, Jing Liu, Hui Cheng, Jianping Zhao, Gang Huang, Wei Wang & Jianfeng Zhou. (2020) Ruxolitinib in treatment of severe coronavirus disease 2019 (COVID-19): A multicenter, single-blind, randomized controlled trial. Journal of Allergy and Clinical Immunology 146:1, pages 137-146.e3.
Crossref
Crossref
Ozlem Altay, Elyas Mohammadi, Simon Lam, Hasan Turkez, Jan Boren, Jens Nielsen, Mathias Uhlen & Adil Mardinoglu. (2020) Current Status of COVID-19 Therapies and Drug Repositioning Applications. iScience 23:7, pages 101303.
Crossref
Crossref
Hua Qing, Reina Desrouleaux, Kavita Israni-Winger, Yann S. Mineur, Nia Fogelman, Cuiling Zhang, Saleh Rashed, Noah W. Palm, Rajita Sinha, Marina R. Picciotto, Rachel J. Perry & Andrew Wang. (2020) Origin and Function of Stress-Induced IL-6 in Murine Models. Cell 182:2, pages 372-387.e14.
Crossref
Crossref
Yong-Jian Geng, Zhi-Yao Wei, Hai-Yan Qian, Ji Huang, Robert Lodato & Richard J. Castriotta. (2020) Pathophysiological characteristics and therapeutic approaches for pulmonary injury and cardiovascular complications of coronavirus disease 2019. Cardiovascular Pathology 47, pages 107228.
Crossref
Crossref
Yvan Jamilloux, Thomas Henry, Alexandre Belot, Sébastien Viel, Maxime Fauter, Thomas El Jammal, Thierry Walzer, Bruno François & Pascal Sève. (2020) Should we stimulate or suppress immune responses in COVID-19? Cytokine and anti-cytokine interventions. Autoimmunity Reviews 19:7, pages 102567.
Crossref
Crossref
Pan Luo, Yi Liu, Lin Qiu, Xiulan Liu, Dong Liu & Juan Li. (2020) Tocilizumab treatment in COVID‐19: A single center experience. Journal of Medical Virology 92:7, pages 814-818.
Crossref
Crossref
Luca Gallelli, Leiming Zhang, Tian Wang & Fenghua Fu. (2020) Severe Acute Lung Injury Related to COVID‐19 Infection: A Review and the Possible Role for Escin. The Journal of Clinical Pharmacology 60:7, pages 815-825.
Crossref
Crossref
E. L. Nasonov. (2020) IMMUNOPATHOLOGY AND IMMUNOPHARMACOTHERAPY OF CORONAVIRUS DISEASE 2019 (COVID-19): FOCUS ON INTERLEUKIN 6. Rheumatology Science and Practice 58:3, pages 245-261.
Crossref
Crossref
Tracey L. Freeman & Talia H. Swartz. (2020) Targeting the NLRP3 Inflammasome in Severe COVID-19. Frontiers in Immunology 11.
Crossref
Crossref
Michelle Willicombe, David Thomas & Stephen McAdoo. (2020) COVID-19 and Calcineurin Inhibitors: Should They Get Left Out in the Storm?. Journal of the American Society of Nephrology 31:6, pages 1145-1146.
Crossref
Crossref
Matthew E. Hartman, Roland A. Hernandez, Krish Patel, Teresa E. Wagner, Tony Trinh, Anne B. Lipke, Eric T. Yim, Juan N. Pulido, John M. PagelSamuel J. Youssef & John L. Mignone. (2020) COVID-19 Respiratory Failure: Targeting Inflammation on VV-ECMO Support. ASAIO Journal 66:6, pages 603-606.
Crossref
Crossref
Aamir Ahmad, Shahab Uddin & Martin Steinhoff. (2020) CAR-T Cell Therapies: An Overview of Clinical Studies Supporting Their Approved Use against Acute Lymphoblastic Leukemia and Large B-Cell Lymphomas. International Journal of Molecular Sciences 21:11, pages 3906.
Crossref
Crossref
Marta Colaneri, Laura Bogliolo, Pietro Valsecchi, Paolo Sacchi, Valentina Zuccaro, Fabio Brandolino, Carlomaurizio Montecucco, Francesco Mojoli, Emanuele Giusti & Raffaele Bruno. (2020) Tocilizumab for Treatment of Severe COVID-19 Patients: Preliminary Results from SMAtteo COvid19 REgistry (SMACORE). Microorganisms 8:5, pages 695.
Crossref
Crossref
Oliver Wegehaupt, Katharina Wustrau, Kai Lehmberg & Stephan Ehl. (2020) Cell Versus Cytokine – Directed Therapies for Hemophagocytic Lymphohistiocytosis (HLH) in Inborn Errors of Immunity. Frontiers in Immunology 11.
Crossref
Crossref
V. S. Smirnov & Areg A. Totolian. (2020) Some opportunities for immunotherapy in coronavirus infection. Russian Journal of Infection and Immunity 10:3, pages 446-458.
Crossref
Crossref
M. Yu. Shchelkanov, L. V. Kolobukhina, O. A. Burgasova, I. S. Kruzhkova & V. V. Maleev. (2020) COVID-19: etiology, clinical picture, treatment. Russian Journal of Infection and Immunity 10:3, pages 421-445.
Crossref
Crossref
Fernanda I Arnaldez, Steven J O'Day, Charles G Drake, Bernard A Fox, Bingqing Fu, Walter J Urba, Vincenzo Montesarchio, Jeffrey S Weber, Haiming Wei, Jon M Wigginton & Paolo Antonio Ascierto. (2020) The Society for Immunotherapy of Cancer perspective on regulation of interleukin-6 signaling in COVID-19-related systemic inflammatory response. Journal for ImmunoTherapy of Cancer 8:1, pages e000930.
Crossref
Crossref
Catalin Constantinescu, Sergiu Pasca, Tiberiu Tat, Patric Teodorescu, Catalin Vlad, Sabina Iluta, Delia Dima, Dana Tomescu, Ecaterina Scarlatescu, Alina Tanase, Olafur Eysteinn Sigurjonsson, Anca Colita, Hermann Einsele & Ciprian Tomuleasa. (2020) Continuous renal replacement therapy in cytokine release syndrome following immunotherapy or cellular therapies?. Journal for ImmunoTherapy of Cancer 8:1, pages e000742.
Crossref
Crossref
E. L. Nasonov. (2020) CORONAVIRUS DISEASE 2019 (COVID-19): A RHEUMATOLOGIST’S THOUGHTS. Rheumatology Science and Practice 58:2, pages 123-132.
Crossref
Crossref
Erin K McCreary & Jason M Pogue. (2020) Coronavirus Disease 2019 Treatment: A Review of Early and Emerging Options. Open Forum Infectious Diseases 7:4.
Crossref
Crossref
Hanping Wang, Ran Tian, Peng Gao, Qian Wang & Li Zhang. (2020) Tocilizumab for Fulminant Programmed Death 1 Inhibitor–Associated Myocarditis. Journal of Thoracic Oncology 15:3, pages e31-e32.
Crossref
Crossref